Hosted on MSN

Smallcap stock with strong sales guidance and 20% CAGR target for FY26 to keep an eye on

Bengaluru, June 23 -- Leading real estate stock is poised for robust growth in FY26, driven by strong sales volumes and improved collections. Management executives forecast a healthy compound annual ...
Hosted on MSN

Novartis sees +5%-6% sales CAGR cc for 2025-2030

Novartis (NVS) rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in London and reflects ...